8V08 image
Deposition Date 2023-11-17
Release Date 2024-03-13
Last Version Date 2024-06-19
Entry Detail
PDB ID:
8V08
Keywords:
Title:
Crystal structure of human PLD4 co-crystallized with 5'Pi-ssDNA
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.31
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:5'-3' exonuclease PLD4
Gene (Uniprot):PLD4
Chain IDs:A
Chain Length:488
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:5'-3' exonuclease PLD4
Gene (Uniprot):PLD4
Chain IDs:B
Chain Length:488
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Molecule:ssDNA
Chain IDs:C, D
Chain Length:3
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
NEP A HIS modified residue
Ligand Molecules
Primary Citation
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4.
Structure 32 766 779.e7 (2024)
PMID: 38537643 DOI: 10.1016/j.str.2024.02.019

Abstact

Endolysosomal exonucleases PLD3 and PLD4 (phospholipases D3 and D4) are associated with autoinflammatory and autoimmune diseases. We report structures of these enzymes, and the molecular basis of their catalysis. The structures reveal an intra-chain dimer topology forming a basic active site at the interface. Like other PLD superfamily members, PLD3 and PLD4 carry HxKxxxxD/E motifs and participate in phosphodiester-bond cleavage. The enzymes digest ssDNA and ssRNA in a 5'-to-3' manner and are blocked by 5'-phosphorylation. We captured structures in apo, intermediate, and product states and revealed a "link-and-release" two-step catalysis. We also unexpectedly demonstrated phosphatase activity via a covalent 3-phosphohistidine intermediate. PLD4 contains an extra hydrophobic clamp that stabilizes substrate and could affect oligonucleotide substrate preference and product release. Biochemical and structural analysis of disease-associated mutants of PLD3/4 demonstrated reduced enzyme activity or thermostability and the possible basis for disease association. Furthermore, these findings provide insight into therapeutic design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures